HOME » Inhibitors and Compound Libraries » EIDD-2801 (SARS-CoV Inhibitor)

EIDD-2801 (SARS-CoV Inhibitor)

CSNPharm
1 2 3 4 5
(0/5) Be the first to review.
 
No price

Information

Details

EIDD-2801 is an orally bioavailable prodrug of EIDD-1931, which has a broad-spectrum antiviral activity against 39 multiple coronaviruses, including SARS-CoV2, MERS-CoV, SARS-CoV. and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor.

For research Use Only

Specifications

 
Partno: CSN25551

Opinions

Add review

RFre
Code from Captcha-image:

Rating (0)

Product documents

Document (0)

Other products of the same brand

  • Anti-COVID-19 Compound Library
    Anti-COVID-19 Compound Library
    CSNPharm
    Details A collection of 103 anti-COVID-19 compounds for HTS and HCS and an e...
    Art. no. CSN-L1025
    No price
    •   Back